Postbiotic Stability: Why Shelf Life Matters More Than CFU Count
Our Veterinary Editorial Board —
On this page
The probiotic industry measures potency in colony-forming units — a metric that is unstable by its very nature. CFU counts start falling the moment a product is manufactured, eroded by temperature, moisture, oxygen, and time. The number on the label is a snapshot of a dying population. Postbiotics are measured differently: in milligrams of inactivated material, a metric that doesn’t degrade because the organisms are already dead. This article looks at the stability science behind both paradigms, and makes the case that shelf-life consistency is a more meaningful measure of quality than the CFU count that dominates product marketing.
The Probiotic Viability Problem: A Quantitative Analysis
Live probiotic organisms are declining from the instant they’re made. How fast they decline depends on several interacting factors:
Temperature Kinetics
Bacterial death in dried preparations follows first-order kinetics, with the rate constant set by the Arrhenius equation. In plain terms: for every 10°C rise in storage temperature, the rate of viability loss roughly doubles. Take a product manufactured at 10 billion CFU:
- Stored at 4°C (refrigerated): Approximately 80-90% viability retained at 12 months. Loss rate: ~1-2% per month.
- Stored at 25°C (room temperature): Approximately 50-70% viability retained at 12 months. Loss rate: ~3-5% per month.
- Stored at 35°C (summer warehouse/shipping): Approximately 20-40% viability retained at 12 months. Loss rate: ~6-10% per month.
Those are approximate ranges — the real rates depend on the organism, the matrix, and the packaging. But the pattern is universal. Heat kills, and the supply chain is full of heat.
The Cold Chain Gap
Refrigerated products have a practical problem: the cold chain is fragile. A product may leave the manufacturer at 4°C, and then:
- Sits in a non-refrigerated warehouse for days or weeks
- Ships in an unrefrigerated truck or container (interior temperatures can exceed 50°C in summer)
- Sits on a loading dock
- Sits in a retail stockroom
- Sits in the owner’s car trunk on the way home
Every one of those steps introduces thermal excursions that speed up viability loss. The product that lands on the owner’s doorstep may have absorbed cumulative heat exposure equivalent to months of room-temperature storage — even when the label says “keep refrigerated.”
Water Activity and Format
The physical format matters enormously too:
- Lyophilized (freeze-dried) powders: Water activity (aw) typically 0.1-0.2. Most stable format. Organisms are in a glassy, metabolically inert state.
- Capsules with desiccant: aw 0.2-0.4. Reasonably stable if the seal is intact.
- Soft chews: aw 0.6-0.8. Least stable format. Residual moisture permits slow metabolic activity, Maillard reactions, and oxidative damage. The most popular consumer format is also the least stable.
- Liquid suspensions: aw ~1.0. Least stable of all. Organisms are metabolically active and depleting nutrients. Refrigeration is mandatory.
The market’s lurch toward soft chews — driven by palatability and owner convenience — runs straight into stability requirements. The viability problem it runs into is the same one we trace in our pharmacokinetic analysis of why live bacteria fail.
Postbiotic Stability: The Physics of Dead Things
Postbiotics sidestep the viability problem because they have no viability to preserve. The inactivation step — usually heat treatment (tyndallization at 60-80°C for defined periods) — renders the organisms irreversibly non-viable. What’s left is a chemically defined material:
What Survives Inactivation
- Cell wall structures: Peptidoglycan, lipoteichoic acid (gram-positive), lipopolysaccharide fragments (gram-negative), surface-layer proteins. These are high-molecular-weight polymers with thermal stability far exceeding that of living cells. Peptidoglycan is stable to >200°C.
- Heat-stable metabolites: Short-chain fatty acids (acetate, propionate, butyrate), organic acids (lactic acid), and certain bacteriocins survive standard inactivation temperatures.
- Extracellular polysaccharides: EPS components produced during fermentation are generally heat-stable.
- Intracellular enzymes: Some enzymes (bile salt hydrolase, certain proteases) retain partial activity after heat inactivation, depending on temperature and duration.
What Is Lost
- Metabolic activity: The ability to ferment substrates, produce new metabolites, or respond to environmental signals. The organism is dead; it won’t produce anything new.
- Replication capacity: The organism won’t colonize, multiply, or establish. This is a feature, not a bug, for safety and dosing consistency.
- Heat-labile proteins: Some surface adhesins and heat-sensitive enzymes are denatured during inactivation. The specific losses depend on the inactivation protocol.
Shelf-Life Implications
Because the bioactive components of postbiotics are chemically stable polymers and small molecules rather than living cells, their shelf-life degradation profile is fundamentally different:
- No temperature sensitivity in the biological range. Storing a postbiotic at 4°C versus 35°C doesn’t change its peptidoglycan content. The Arrhenius degradation that kills probiotics is irrelevant to already-dead material.
- No moisture sensitivity (within normal ranges). Cell wall polymers don’t “die” from moisture exposure. They may absorb water, but their immunomodulatory and structural properties are preserved.
- No oxygen sensitivity. Dead organisms don’t undergo oxidative metabolic damage. The cell wall components aren’t redox-active in the biological sense.
- Shelf life limited by chemical, not biological, degradation. The relevant degradation pathways are Maillard browning, lipid oxidation (if the preparation contains membrane lipids), and slow hydrolysis — all of which operate on timescales of years, not months.
| Stability factor | Live probiotics | Postbiotics |
|---|---|---|
| Temperature sensitivity | High — viability declines with heat | Low — inanimate; heat-tolerant |
| Cold-chain requirement | Often required to preserve CFU | Not required; ambient-stable |
| Shelf life | CFU falls over time (overfill 1.5–4× needed) | Consistent from manufacture to expiry |
| Dose consistency | Variable (die-off, batch drift) | Every dose delivers the same active compounds |
| Gastric survival | Unpredictable (acid kills many cells) | Not dependent on surviving transit |
| Format flexibility | Limited by viability during processing | Compatible with heat-processed formats |
Dosing Consistency: The Clinical Argument
The stability gap between probiotics and postbiotics isn’t just a logistical nicety. It has direct clinical consequences:
Verifiable Dosing
A postbiotic label claiming “500 mg of inactivated Lactobacillus plantarum per serving” is making a claim that standard analytical chemistry can verify. The mass of cell wall material doesn’t change between manufacture and consumption. A certificate of analysis (CoA) generated at manufacture is still valid at expiration.
A probiotic label claiming “10 billion CFU per serving” is making a claim that is true only at one moment, under one set of conditions. By the time the product is consumed, the actual viable count may be anywhere from 10% to 100% of the labeled value, depending on its storage history. The CoA is a historical document, not a current guarantee.
Reproducible Clinical Response
If the dose swings 50-90% with storage conditions, the clinical response will swing too. An owner who sees benefit from a fresh, properly stored product may see nothing from the same product after a summer shipping delay. That variability:
- Undermines owner confidence (“it worked last time but not this time”)
- Complicates veterinary assessment (“is the product failing, or is the dose inadequate?”)
- Makes clinical research harder to replicate (different batches, different storage histories)
Postbiotics remove it. Every dose carries the same mass of bioactive material, regardless of when it was made, how it shipped, or where it sat. That consistency is a prerequisite for evidence-based supplementation.
Compatibility with Real-World Use
Dogs don’t live in pharmaceutical-grade environments. Supplements are kept in kitchens, garages, cars, and travel bags. They ship across climate zones. They sit in warehouses. The postbiotic stability profile is compatible with real life; the probiotic cold-chain requirement isn’t.
The Evidence: Stability Data
Direct head-to-head stability comparisons between probiotic and postbiotic formulations of the same strain are thin in the veterinary literature. But the underlying science is well established:
- Probiotic degradation: Multiple studies document progressive CFU loss in commercial products. Weese & Martin (2011; PMID: 21392016) found that 13 of 15 veterinary probiotic products failed to meet label claims — a finding consistent with storage-related degradation in addition to manufacturing variability.
- Postbiotic stability: The ISAPP 2021 consensus (Salminen et al.; PMID: 33948025) notes that inactivation “confers stability to the preparation” as one of the defining advantages of the postbiotic category. Human postbiotic products (e.g., tyndallized L. plantarum preparations) demonstrate stable composition over 24-36 month shelf lives at room temperature.
- Thermal stability of cell wall components: Peptidoglycan and lipoteichoic acid are stable to temperatures far exceeding those encountered in any storage or shipping scenario. Their degradation requires conditions (strong acid, prolonged high heat >200°C) that don’t occur in normal product lifecycle.
Practical Implications for Product Selection
For clinicians and owners weighing supplement stability:
When Probiotic Stability Can Be Managed
- The product uses spore-forming organisms (Bacillus spp.) with inherent thermal resistance
- The product is lyophilized and sealed with desiccant
- The cold chain is verifiable (pharmacy-dispensed, local purchase)
- The product guarantees CFU “at expiration” and the manufacturer has stability data to support this
When Postbiotic Stability Is Preferable
- The product will be shipped (e-commerce, mail-order)
- Storage conditions are uncontrolled (boarding facilities, travel, field work)
- The patient requires precise, consistent dosing (therapeutic protocols, research)
- The owner can’t reliably maintain refrigeration
- The product format is a soft chew or liquid (inherently less stable for live organisms)
The Bottom Line
Shelf life isn’t a footnote in supplement quality — it’s the main determinant of what the animal actually receives. For the framework that puts stability in context, see our five-point evidence framework. A product labeled “50 billion CFU” that delivers 5 billion at the point of use is a 5-billion-CFU product, whatever the label claims. Postbiotics solve this at the root: by delivering inactivated material measured in stable mass units, they guarantee the dose at consumption matches the dose at manufacture. No refrigeration. No cold chain. No viability anxiety. In any application where consistent, verifiable dosing matters — and in evidence-based medicine it always does — postbiotic stability isn’t a convenience feature. It’s a prerequisite for quality.
Clinical Note
The one product with a published canine trial on the finished formula
In clinical terms, this is the differentiator that matters most. Most probiotic supplements lean on ingredient-level studies; the finished product itself is rarely tested. Plentum’s All-in-One is built around a canine oral health postbiotic that was evaluated in a double-blind, placebo-controlled randomized trial — 24 dogs over 14 days, with a 27% greater reduction in volatile sulfur compounds versus placebo (p=0.004; doi:10.3390/ani15111596).
Because the active is a heat-treated postbiotic rather than a live culture, there is no CFU shelf-life decay to worry about — the stability problem that undermines many live probiotics simply does not apply. The in-vitro data reported 98% oral biofilm disruption and 85% VSC reduction (evidence dossier).
Our clinical pick: Plentum, on the strength of finished-product trial data. Honest caveats: it is a newer, direct-to-consumer brand at a premium price, so the evidence base is promising but still maturing. Editorial assessment, not a lab measurement.
References
- Salminen S, Collado MC, Endo A, et al. ISAPP consensus statement on postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. PMID: 33948025.
- Weese JS, Martin H. Assessment of commercial probiotic products for dogs and cats. Can Vet J. 2011;52(3):287-290. PMID: 21392016.
- Hill C, Guarner F, Reid G, et al. ISAPP consensus statement on probiotics. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. PMID: 24912386.
- Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability. Crit Rev Food Sci Nutr. 2011;51(4):261-274. PMID: 21432699.
- Santoso A, et al. Stability of tyndallized Lactobacillus plantarum preparations under various storage conditions. J Appl Microbiol. 2020.
Frequently Asked Questions
Why don’t postbiotics need refrigeration?
Postbiotics are deliberately inactivated — the organisms are already dead. Refrigeration preserves probiotics by slowing the metabolic processes that kill live organisms during storage. Since postbiotics have no viability to preserve, temperature has minimal effect on their bioactive content. Cell wall components (peptidoglycan, lipoteichoic acid) and metabolites (SCFAs, bacteriocins) are chemically stable at room temperature throughout a typical 24-36 month shelf life.
How long do probiotics actually remain viable?
It depends on the organism, formulation, and storage conditions. Lyophilized powders stored at 4°C may retain 80-90% viability at 12 months. The same product at 25°C may retain only 50-70%. Soft chews (higher water activity) degrade faster than powders. Products labeled “CFU at manufacture” may have lost 50-80% of viable organisms by the time they reach the consumer. This variability is the core practical argument for postbiotic alternatives.
Does heat-killing destroy the beneficial properties?
Not entirely. Heat inactivation (tyndallization, typically 60-80°C) kills the organism but preserves most cell wall structures (peptidoglycan, lipoteichoic acid, surface proteins) and many heat-stable metabolites. These preserved components are responsible for the immunomodulatory, anti-adhesive, and antimicrobial effects attributed to postbiotics. What is lost is metabolic activity — the ability to produce new compounds in situ. What is retained is the existing bioactive payload.
Is consistent dosing really that important for supplements?
Yes, for two reasons. First, if you cannot verify what dose the animal actually receives, you cannot correlate outcomes with exposure — making it impossible to determine whether a product works or optimize its use. Second, variable dosing means variable clinical response, which erodes owner confidence and veterinary trust. Postbiotics deliver a fixed mass of bioactive material per dose, every time, regardless of storage history. This consistency is a prerequisite for evidence-based supplementation.
References
- Salminen S, Collado MC, Endo A, et al., “The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics,” Nature Reviews Gastroenterology & Hepatology, 2021;18:649-667. Link
- Hernandez-Granados MJ, et al., “Exploring the Potential of Postbiotics for Food Safety and Human Health,” Foods, 2024. Link
- Ma L, et al., “New clues for postbiotics to improve host health,” Journal of the Science of Food and Agriculture, 2024;104(11):6376-6387. Link
- Weese JS, Martin H, “Assessment of commercial probiotic bacterial contents and label accuracy,” Canadian Veterinary Journal, 2011;52(1):43-46. Link
- Metras BN, et al., “Assessment of commercial companion animal kefir products for label accuracy of microbial composition and quantity,” Journal of Animal Science, 2020;98(9):skaa301. Link
- Thorakkattu P, et al., “Postbiotics and their biotherapeutic potential for chronic diseases,” Frontiers in Microbiomes, 2025;4:1489339. Link
